Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 USD | -3.78% | -12.75% | -2.47% |
Mar. 13 | Top Premarket Decliners | MT |
Mar. 12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.47% | 383M | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-0.82% | 21.48B | |
-18.14% | 20.82B | |
-7.26% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- iTeos Therapeutics : Wedbush Raises Price Target for iTeos Therapeutics Ahead of Potentially Upbeat EOS-448 Data, Maintains Outperform Rating